A Phase I Clinical Study of SSS59 Monotherapy in Patients With Advanced Malignant Tumors
NCT06944444 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 154
Last updated 2025-04-29
Summary
This study was an open-label phase I study to evaluate the safety, pharmacokinetics, and antitumor activity of SSS59 as a single agent in patients with advanced malignancies.
Conditions
- Malignant Tumors
Interventions
- DRUG
-
SSS59
A humanized antibody targeting MUC17
Sponsors & Collaborators
-
Shenyang Sunshine Pharmaceutical Co., LTD.
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-27
- Primary Completion
- 2027-03-01
- Completion
- 2027-12-31
Countries
- China
Study Locations
More Related Trials
-
A Clinical Study to Evaluate the Efficacy and Safety of SI-B001 in the Treatment of Recurrent and Metastatic HNSCC
NCT05044897 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Surufatinib Combined With Chemotherapy Plus Toripalimab or Not in the Treatment of Small Cell Lung Cancer
NCT04996771 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Phase I Study of SIM0686 in Participants With Locally Advanced/Metastatic Solid Tumors
NCT07050459 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase I Study of SPGL008 in Subjects With Advanced Malignant Tumors
NCT07038005 ·Status: RECRUITING ·Phase: PHASE1
-
Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma
NCT04398056 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of LM-299 in Subjects Advanced Malignant Tumors
NCT06650566 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Study of Surufatinib Single Agent or Surufatinib Combined With Toripalimab in Patients With Advanced Solid Tumors
NCT04169672 ·Status: COMPLETED ·Phase: PHASE2
-
Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB41 in Adult Patients with Advanced Malignant Solid Tumours.
NCT06600022 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase I/II Clinical Trial of LBL-015 for Injection
NCT05107011 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Toripalimab as Consolidation Therapy After Postoperative Chemoradiotherapy in HNSCC
NCT04992559 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Study of SPH6516 Tablets in the Treatment of Advanced Solid Tumors.
NCT06266923 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
An Open-label Study of SG1827 in Subjects With Advanced Solid Tumors
NCT06076291 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Clinical Study to Evaluate Safety, Tolerance, Pharmacokinetics and Efficacy of Sc610 Injection for Treating Advanced Urinary System Tumors
NCT05633589 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid Tumors
NCT05153096 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients
NCT07171606 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
NCT05396391 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Clinical Trial of Chemotherapy With Lobaplatin and 5-FU in Recurrent Local or Distant Advanced NPC.
NCT03210389 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of CS1001 in Subjects With Stage IV Non-Small Cell Lung Cancer
NCT03789604 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of Safety, Tolerability and Pharmacokinetics of Nivolumab in Chinese Subjects With Previously Treated Advanced or Recurrent Solid Tumors
NCT02593786 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
NCT06666270 ·Status: RECRUITING ·Phase: PHASE1
-
First-line Treatment for ES-SCLC with Chemotherapy Combined with PD-1/PD-L1 Inhibitor Sequential Thoracic Radiotherapy
NCT06586697 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer
NCT05949606 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer
NCT02943252 ·Status: UNKNOWN ·Phase: PHASE2
-
Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal Carcinoma
NCT05869227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase I Study Of JS015 in Patients With Advanced Solid Tumors
NCT05770310 ·Status: UNKNOWN ·Phase: PHASE1